Partners
Working closely with the global health community, governments, industry, academia, and philanthropy, the International Vaccine Institute is uniquely present at every step of the vaccine value chain – from new vaccine design in the laboratory, to vaccine development and evaluation in the field, to facilitating sustainable introduction of vaccines in countries where they are most needed.
It is through collaboration with partners that we work to fulfill our mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health. Together, we advance global health and UN Sustainable Development Goals by turning vaccine science into real-world impact.
If you or your organization shares our vision of a world free of suffering from infectious diseases through vaccines, please contact us at iviinfo@www.ivi.int about partnership opportunities.
IVI has 160 partners worldwide spanning government, industry, academia, civil society, and intergovernmental organizations
Major partners
Industry
Technology transfer and vaccine development partnerships with manufacturers
Host countries
Engagement with all sectors, in addition to government ministries and agencies, in host countries Republic of Korea, Sweden, Austria, and Rwanda.
Government
Partnerships to develop vaccines and build capacity in low- and middle-income countries
Global health
Conducting public health research and immunization campaigns in collaboration with health ministries and organizations
Philanthropy
Implementation of vaccine development programs, clinical trials, disease burden studies, and effectiveness studies with support from philanthropic bodies
Academia
Scientific collaborations with universities, academic societies, research institutes, and medical associations